Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

EdgeRx vs WePeptideRx

By GLP-1 ScorecardUpdated

EdgeRxFactor scores not reassessed.
Site position #42

Higher score

WePeptideRxFactor scores not reassessed.
Site position #321

Lower score

Score comparison

EdgeRx has the higher recorded score — 79/100 to 61.4/100.

EdgeRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. EdgeRx lists compounded GLP-1 injections in a men’s health program. Its terms say the final charge can vary with the prescription and pharmacy.

Before you choose

Before comparing the headline prices, the EdgeRx review and the WePeptideRx review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, AHBARx vs EdgeRx and Effecty vs WePeptideRx compare each of them with another graded program, and the list of alternatives to EdgeRx ranks the programs closest to EdgeRx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the MyDrHank review covers one graded close to these two, at 68.2/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueEdgeRx +22
70
48
Dose & formulationEdgeRx +11
75
64
Clinical oversightEdgeRx +7
88
81
Labs & monitoringEdgeRx +25
78
53
FulfillmentEdgeRx +23
90
67
Contract termsEdgeRx +25
80
55
EdgeRx · top barWePeptideRx · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricEdgeRxWePeptideRx
WeighScore79/10061.4/100
GradeC+C
Site position#42#321
SemaglutideAdvertised $199/mo; confirm final prescription chargeFrom $149 per 30-day supply (advertised discount, compounded)
TirzepatideAdvertised $225/mo; confirm final prescription chargeFrom $159 per 30-day supply (advertised discount, compounded)
Coverage47 states advertised; excludes Arkansas, Indiana and South CarolinaCoverage varies by treatment and state
Brand-name accessNot confirmedYes
Oral / sublingualNot confirmedNot confirmed
EdgeRx

Site position #42 · C+

Factor scores not reassessed.

Strengths

  • Publishes separate semaglutide and tirzepatide prices
  • Names Strive as its primary 503A pharmacy in its terms
  • Advertises included shipping and physician review

What to consider

  • The final charge may vary with the prescribed product and dispensing pharmacy
  • The homepage’s approval refund language needs to be reconciled with the consultation fee and final-sale terms
WePeptideRx

Site position #321 · C

Factor scores not reassessed.

Strengths

  • Lists compounded and brand-name treatment options
  • Advertises consultation and shipping in the treatment price
  • Publishes a refund process for clinically declined items

What to consider

  • Charges at checkout before clinical review
  • The public discount does not establish the next bill
  • Medication refunds are unavailable after dispensing and shipping

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard